Physician profile
Jad Raffoul
NPI 1194004952
$6,056.29
in general payments reported to CMS, 2019-2025
23 companies · $540 in 2025
The $540 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $224 · 2021: $463 · 2022: $197 · 2023: $3,219 · 2024: $1,026 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,487 · Travel and Lodging: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,486.66 |
| Travel and Lodging | $1,298.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,453.45 | 2020-2025 | Angiojet Ultra 5000a, Eluvia, General - Thrombectomy |
| Cagent Vascular INC | $428.26 | 2023-2024 | Serrantor |
| Abiomed | $381.51 | 2020-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $307.33 | 2019-2022 | |
| Pfizer INC. | $231.92 | 2021-2025 | |
| Philips North America LLC | $178.35 | 2019-2025 | (Ck4) Mcot, Labosys |
| Shockwave Medical, INC | $162.68 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $128.73 | 2022-2024 | |
| Medtronic Vascular, INC. | $124.53 | 2019 | |
| Recor Medical INC | $109.47 | 2024 | Paradise Renal Denervation System |
| Amgen INC. | $101.00 | 2021-2024 | Repatha |
| Amarin Pharma, INC. | $81.14 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.57 | 2023-2024 | Lifevest |
| Penumbra, INC. | $46.93 | 2020 | |
| Cardiovascular Systems INC. | $45.86 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $43.25 | 2021 | |
| Merck Sharp & Dohme LLC | $38.29 | 2021 | |
| Angiodynamics, INC. | $34.90 | 2023 | Auryon Laser System 100-120 Vac |
| E.R. Squibb & Sons, L.L.C. | $28.86 | 2022 | |
| W. L. Gore & Associates, INC. | $23.52 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bardy Diagnostics, INC. | $21.53 | 2021 | |
| Cvrx, INC. | $18.28 | 2023 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jad Raffoul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.